Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits (Q44673823)

5 December 2017

Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits (English)

1 reference

5 December 2017

1 reference

1 reference

11

1 reference

5 December 2017

12

1 reference

5 December 2017

Norbert Weissmann

5

0 references

Ralph T Schermuly

object named as

Ralph T Schermuly

4

0 references

Karin Quanz

9

object named as

Karin Quanz

1 reference

5 December 2017

10

Leander Ermert

1 reference

5 December 2017

3

Monika Ermert

1 reference

5 December 2017

7

Philipp Markart

1 reference

5 December 2017

8

Clemens Ruppert

1 reference

5 December 2017

Andreas Günther

1

1 reference

5 December 2017

Norbert Lübke

2

1 reference

5 December 2017

Andreas Breithecker

6

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

5 December 2017

1 reference

5 December 2017

168

1 reference

5 December 2017

1358-1365

1 reference

5 December 2017

11

1 reference

New strategies for treatment of pulmonary fibrosis

5 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Pulmonary surfactant in health and human lung diseases: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Alveolitis and collapse in the pathogenesis of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Pulmonary fibrosis correlates with duration of tissue neutrophil activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Aerosols for systemic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Role of thrombin and its major cellular receptor, protease-activated receptor-I, in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2201082

21 January 2018

Identifiers

DOI

10.1164/RCCM.2201082

1 reference

5 December 2017

1 reference